Skip to content
Belgian Medicines Verification Organisation

Belgian Medicines Verification Organisation

VZW
  • Home
  • BeMVO
    • Governance
    • Members
    • EMVO
    • Medicines Verification System
  • MAH
    • Marketing Authorization Holders (MAH)
    • Registration MAH
  • End Users
    • On boarding of end users
      • Wat is an end user?
      • Who are the end users of the verification system?
      • HOW CAN END USERS ON BOARD TO THE VERIFICATION SYSTEM
      • Contractual on boarding by end users
      • Development portal and implementation support
      • Access Request Verification by BeMVO – Contractual part
      • Development of the access module
      • Technical implementation
    • End user access to the Medicines Verification System
    • End User – SOFTWARE SUPPLIERS
  • FAQ
  • News
  • Contact
  • en

© Copyright 2021


DISCLAIMER – All information on this website is based on the current available understanding and interpretation of the Directive 2011/62/EU and the Delegated Regulation 2016/161 by the European and Belgian competent authorities and by the stakeholder associations at European and Belgian level. Final conclusions and legislation emitted by the competent authorities might result in a different application of the Directive and Delegated Regulation in Belgium.

Site by DataConnect.be

COVID-19

 

Omwille van COVID-19 zijn de kantoren van BeMVO niet altijd telefonisch beschikbaar.
Daarom is het aangewezen om BeMVO best via email te contacteren voor alle vragen.

A cause de COVID-19, le bureau BeMVO n’est pas toujours joignable par téléphone.
Pour cette raison nous vous conseillons de contacter BeMVO de préférence par email pour toute question.

Due to Covid-19, you can not always contact our office by phone.
We kindly invite you to use following email addresses for questions

Wholesalers :  whs@bemvo.be

Pharmacies:    pha@bemvo.be

Hospitals:        hosp@bemvo.be

MAH:               MAH@bemvo.be

Dank voor uw begrip.
Nous vous remercions pour votre compréhension.
Thank you.